MORGAN STANLEY PLC/CALL/CVS HEALTH/100/0.1/20.12.24 Share Price

Warrant

DE000MB33TJ0

Market Closed - Börse Stuttgart 12:03:57 04/07/2024 am IST
0.026 EUR -13.33% Intraday chart for MORGAN STANLEY PLC/CALL/CVS HEALTH/100/0.1/20.12.24
Current month-13.33%
1 month-7.14%
Date Price Change
03/24/03 0.026 -13.33%
02/24/02 0.03 0.00%
01/24/01 0.03 0.00%
28/24/28 0.03 -3.23%
27/24/27 0.031 -3.13%

Delayed Quote Börse Stuttgart

Last update July 04, 2024 at 12:03 am IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying CVS HEALTH CORPORATION
Issuer Morgan Stanley
WKN MB33TJ
ISINDE000MB33TJ0
Date issued 01/02/2023
Strike 100 $
Maturity 20/12/2024 (170 Days)
Parity 10 : 1
Emission price 0.81
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 0.91
Lowest since issue 0.015
Delta0.05x
Omega 8.311
Premium76.99x
Gearing159.37x
Moneyness 0.5670
Difference Strike 43.3 $
Difference Strike %+43.30%
Spread 0.014
Spread %35.00%
Theoretical value 0.0330
Implied Volatility 46.68 %
Total Loss Probability 97.35 %
Intrinsic value 0.000000
Present value 0.0330
Break even 100.36 €
Theta-0x
Vega0x
Rho0x

Company Profile

CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®); - medical benefits management (25.8%); - other (0.1%).
Sector
-
More about the company

Ratings for CVS Health Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: CVS Health Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
56.7 USD
Average target price
69.1 USD
Spread / Average Target
+21.86%
Consensus